Predictive Biomarkers for Mortality Risk Assessment in Geriatric Individuals Following COVID-19 Booster Vaccination: A District-Level Study from Assam, India
International Journal of Drug Delivery Technology · 29.04.2026 · 16 (30s)
DOI: 10.25258/ijddt.16.30s.115 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 29.04.2026. Verfasst von Shahinur Islam und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Cardiovascular and respiratory diseases remain major contributors to morbidity and mortality among elderly individuals due to age-related physiological decline, multimorbidity, and reduced immune responsiveness. Although COVID-19 booster vaccination has demonstrated a favorable safety profile globally, evidence regarding biomarker-based assessment of post-vaccination cardiopulmonary outcomes among geriatric populations in Northeast India remains limited. The present prospective cohort study evaluated predictive biomarkers associated with cardiovascular and respiratory events following COVID-19 booster vaccination among elderly individuals in selected districts of Assam, including Dhubri, Goalpara, Barpeta, and Bongaigaon. A total of 400 participants aged ≥60 years were followed for 12 months using active telephonic surveillance and verification through hospital records to identify incident clinical events. Organ-specific biomarkers, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), C-reactive protein (CRP), peripheral oxygen saturation (SpO₂), serum creatinine, and blood urea nitrogen (BUN), were assessed at baseline and follow-up to evaluate physiological responses after vaccination. During the follow-up period, 24 cardiovascular events and 32 respiratory events were recorded, corresponding to cumulative incidences of 6% and 8%, respectively, with higher event rates observed among participants aged ≥71 years and those with pre-existing comorbidities. Mild but statistically significant elevations in hepatic enzymes and CRP levels were observed; however, these remained within normal clinical limits. No significant changes were detected in renal function markers or oxygen saturation levels. Overall, the findings indicate that COVID-19 booster vaccination was well tolerated among geriatric individuals. Biomarker-guided monitoring may facilitate early identification of high-risk individuals and support evidence-based post-vaccination surveillance strategies in resource-limited regional healthcare settings such as Northeast India.
Zitieren
APA
Islam, S., Nath, B., Debnath, S., & Kapil, M. J. (2026). Predictive Biomarkers for Mortality Risk Assessment in Geriatric Individuals Following COVID-19 Booster Vaccination: A District-Level Study from Assam, India. International Journal of Drug Delivery Technology, 16(30s). https://doi.org/10.25258/ijddt.16.30s.115
Vancouver
Islam S, Nath B, Debnath S, Kapil MJ. Predictive Biomarkers for Mortality Risk Assessment in Geriatric Individuals Following COVID-19 Booster Vaccination: A District-Level Study from Assam, India. International Journal of Drug Delivery Technology. 2026;16(30s). doi:10.25258/ijddt.16.30s.115
BibTeX
@article{Islam2026,
author = {Islam, Shahinur and Nath, Bipul and Debnath, Subhashis and Kapil, Manas Jyoti},
title = {Predictive Biomarkers for Mortality Risk Assessment in Geriatric Individuals Following COVID-19 Booster Vaccination: A District-Level Study from Assam, India},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {30s},
doi = {10.25258/ijddt.16.30s.115}
}
EUVIMED